Yisheng Wei

1.4k total citations
23 papers, 452 citations indexed

About

Yisheng Wei is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yisheng Wei has authored 23 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yisheng Wei's work include Colorectal Cancer Treatments and Studies (4 papers), Melanoma and MAPK Pathways (4 papers) and Genetic factors in colorectal cancer (3 papers). Yisheng Wei is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Melanoma and MAPK Pathways (4 papers) and Genetic factors in colorectal cancer (3 papers). Yisheng Wei collaborates with scholars based in China, United Kingdom and United States. Yisheng Wei's co-authors include Chuyuan Hong, Isamu Adachi, Jiachun Lü, Dianke Chen, Lei Yang, Ping Lan, Lei Wang, Xinhui Fu, Guoying Wang and Shan Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Yisheng Wei

23 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yisheng Wei China 12 202 199 162 81 55 23 452
Namiko Yada-Hashimoto Japan 9 134 0.7× 244 1.2× 127 0.8× 65 0.8× 63 1.1× 10 551
Shuier Zheng China 13 144 0.7× 269 1.4× 109 0.7× 94 1.2× 110 2.0× 31 431
Chengyun Yao China 13 138 0.7× 271 1.4× 132 0.8× 45 0.6× 122 2.2× 27 482
Renba Liang China 10 145 0.7× 212 1.1× 150 0.9× 57 0.7× 53 1.0× 14 400
Hongyu Gao China 13 214 1.1× 334 1.7× 191 1.2× 207 2.6× 81 1.5× 29 626
Kosuke Yanai Japan 12 259 1.3× 399 2.0× 143 0.9× 96 1.2× 40 0.7× 18 628
Bettina Grötsch Germany 9 102 0.5× 200 1.0× 93 0.6× 174 2.1× 28 0.5× 12 478
Yixiong Liu China 13 157 0.8× 252 1.3× 123 0.8× 50 0.6× 85 1.5× 38 547
Haiyan Dai China 11 75 0.4× 232 1.2× 130 0.8× 76 0.9× 28 0.5× 22 374
Na Zhou China 14 156 0.8× 266 1.3× 223 1.4× 99 1.2× 55 1.0× 33 488

Countries citing papers authored by Yisheng Wei

Since Specialization
Citations

This map shows the geographic impact of Yisheng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yisheng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yisheng Wei more than expected).

Fields of papers citing papers by Yisheng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yisheng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yisheng Wei. The network helps show where Yisheng Wei may publish in the future.

Co-authorship network of co-authors of Yisheng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yisheng Wei. A scholar is included among the top collaborators of Yisheng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yisheng Wei. Yisheng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Weiqun, Zhiliang Huang, Shicai Chen, et al.. (2021). The effectiveness of EVOSKIN®Palm and sole moisturizing cream in treating capecitabine-associated hand-foot syndrome: a randomized double-blind clinical trial. Annals of Palliative Medicine. 10(3). 3009–3017. 11 indexed citations
2.
Wang, Shan, et al.. (2019). Heterotypic cell-in-cell structures in colon cancer can be regulated by IL-6 and lead to tumor immune escape. Experimental Cell Research. 382(1). 111447–111447. 21 indexed citations
3.
Wei, Yisheng, et al.. (2018). The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer. Asia-Pacific Journal of Clinical Oncology. 14(5). e243–e251. 53 indexed citations
4.
Wei, Yisheng, et al.. (2017). The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy. Cancer Biomarkers. 20(4). 627–635. 10 indexed citations
5.
Sun, Lei, Jia Ke, Zhen He, et al.. (2017). HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins. Journal of Cancer. 8(14). 2802–2808. 74 indexed citations
6.
Wang, Jianping, Jun Huang, Yisheng Wei, et al.. (2017). The association between survivin −31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population. Journal of Cancer Research and Therapeutics. 15(1). 82–82. 2 indexed citations
7.
Wei, Yisheng, et al.. (2015). [Impact of platelet count on prognosis of stage II-III colorectal cancer receiving adjuvant chemotherapy].. PubMed. 18(12). 1261–4. 3 indexed citations
8.
Peng, Hui, Jun Huang, Ying Hu, et al.. (2015). Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report. Cellular Oncology. 38(2). 165–172. 2 indexed citations
9.
Hong, Chuyuan, Jing Peng, Yisheng Wei, et al.. (2013). The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer. BMC Cancer. 13(1). 177–177. 30 indexed citations
10.
Hong, Chuyuan, et al.. (2013). Associations between lifestyles and neutrophil‐lymphocyte and platelet‐lymphocyte ratios in colorectal cancer. Asia-Pacific Journal of Clinical Oncology. 10(2). 168–174. 8 indexed citations
11.
Huang, Qinghua, Dianke Chen, Xinhui Fu, et al.. (2013). A genetic variation of the p38β promoter region is correlated with an increased risk of sporadic colorectal cancer. Oncology Letters. 6(1). 3–8. 12 indexed citations
12.
Wei, Yisheng, et al.. (2012). [Clinicopathological features and prognosis of colorectal cancer patients with preoperative cancer-related anemia].. PubMed. 15(4). 385–7. 2 indexed citations
13.
Wei, Yisheng, et al.. (2012). [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].. PubMed. 32(11). 1663–6. 4 indexed citations
14.
Wang, Lei, Jun-Xiao Zhang, Dianke Chen, et al.. (2011). Mitogen/Extracellular Signal-Regulated Kinase Kinase-5 Promoter Region Polymorphisms Affect the Risk of Sporadic Colorectal Cancer in a Southern Chinese Population. DNA and Cell Biology. 31(3). 342–349. 4 indexed citations
15.
Chen, Dianke, Jiachun Lü, Yanxin Luo, et al.. (2011). Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Carcinogenesis. 32(7). 1043–1049. 9 indexed citations
16.
Chen, Dianke, Jiachun Lü, Jiawei Liao, et al.. (2011). NFκB1 and NFκBIA Polymorphisms Are Associated with Increased Risk for Sporadic Colorectal Cancer in a Southern Chinese Population. PLoS ONE. 6(6). e21726–e21726. 64 indexed citations
17.
Liu, Bin, Dianke Chen, Lei Yang, et al.. (2010). A functional variant (−1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Carcinogenesis. 31(8). 1405–1411. 39 indexed citations
18.
Zeng, Zhiyong, et al.. (2009). Are batroxobin agents effective for perioperative hemorrhage in thoracic surgery? A systematic review of randomized controlled trials. Blood Coagulation & Fibrinolysis. 20(2). 101–107. 11 indexed citations
19.
Wei, Yisheng, Lei Wang, Ping Lan, et al.. (2009). The association between −1304T>G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population. International Journal of Cancer. 125(8). 1876–1883. 20 indexed citations
20.
Wei, Yisheng & Isamu Adachi. (1991). Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines.. PubMed. 12(5). 406–10. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Namiko Yada-Hashimoto Breakdown of academic impact, for papers by Shuier Zheng Breakdown of academic impact, for papers by Chengyun Yao Breakdown of academic impact, for papers by Renba Liang Breakdown of academic impact, for papers by Hongyu Gao Breakdown of academic impact, for papers by Kosuke Yanai Breakdown of academic impact, for papers by Bettina Grötsch Breakdown of academic impact, for papers by Yixiong Liu Breakdown of academic impact, for papers by Haiyan Dai Breakdown of academic impact, for papers by Na Zhou
Rankless by CCL
2026